Endress+Hauser Honours Inventors at the 2026 Innovators’ Meeting; 294 Patent Applications and 41 New Products in 2025
June 22, 2026
As disclosed at the recent Endress+Hauser 2026 Innovators’ Meeting, the company filed 294 initial patent applications worldwide last year, launched 41 new products and spent 281.4 million euros on R&D, underscoring its innovative strength in measurement and analytical technology. In total, more than 9,400 active patents and patent applications protect the company’s intellectual property.
The annual Innovators’ Meeting, held in Switzerland, honors the people behind the company’s pioneering achievements. Developers from across the group involved in patent applications come together to exchange ideas and present their most notable inventions. “The Innovators’ Meeting highlights just how much expertise, creativity, teamwork and perseverance go into our products,” says Dr Mirko Lehmann, Chief Technology Officer of the Endress+Hauser Group.
This year’s event marked the 25th anniversary of the first meeting in 2001. (There was no event in 2020 due to the pandemic.) Of the 101 innovators from that first meeting, 35 are still active in the company 25 years later. Fifteen of them filed patents again in 2025. At the same time, 89 inventors from Endress+Hauser were involved in a patent application for the first time.
“Our innovative strength thrives on the collaboration between experienced and new inventors. Endress+Hauser’s long-term focus and values-based culture create an environment where experience is passed on and new ideas can flourish,” says Dr Christine Koslowski, Director of Intellectual Property Rights at Endress+Hauser.
Last year’s R&D investment of 281.4 million euros was an increase of 2.1% from a year earlier and equivalent to 7% of sales.
Endress+Hauser’s innovation efforts are aimed at making industrial processes more efficient and sustainable. In addition to product development, this includes improvements in production, logistics, IT and administration.
With the digitalization of measurement technology, the importance of firmware, connectivity and the instruments’ integration capabilities is becoming more significant. In addition, the company develops software-based solutions and services, including cloud applications and artificial intelligence-based approaches. Another key focus of the innovation efforts is the analysis and measurement of material properties.
About Endress+Hauser Group
Endress+Hauser is a global leader in measurement and automation technology for process and laboratory applications. The family company, headquartered in Reinach, Switzerland, achieved net sales of more than 4.0 billion euros in 2025 with a total workforce of over 18,000. Endress+Hauser devices, solutions and services are at home in many industries. Customers thus use them to gain valuable knowledge from their applications. This enables them to improve their products, work economically and at the same time protect people and the environment.
Endress+Hauser is a reliable partner worldwide. Its own sales companies in more than 50 countries as well as representatives in another 70 countries ensure competent support. Production facilities on four continents manufacture quickly and flexibly to the highest quality standards. The company was founded in 1953 by Georg H Endress and Ludwig Hauser. Ever since, the company has been pushing ahead with the development and use of innovative technologies, now helping to shape the industry’s digital transformation. Over 9,400 patents and applications protect the Group’s intellectual property.
More Information
Related Story
Endress+Hauser Now Boasts Over 9,000 Patents and Patents Pending
On average, Endress+Hauser filed a patent every working day last year. There were 285 first filings for inventions. The family-owned company was granted a total of 701 patents overall, a figure exceeding the number of first filings as inventions are ultimately registered with multiple patent offices. The Group’s portfolio of intellectual property rights now includes over 9,000 active patents and patents pending.
